{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:44:46Z","timestamp":1770813886895,"version":"3.50.1"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Benralizumab improves outcomes in severe eosinophilic asthma (SEA). We aimed to evaluate early effects of benralizumab on airway pathophysiology using functional respiratory imaging (FRI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, single-arm study, 20 adults with SEA underwent CT at baseline, 4 and 12 weeks. Coprimary endpoints were changes in specific airway volume (siVaw) and resistance (siRaw) at functional residual capacity (FRC) and total lung capacity (TLC) at 12 weeks. Imaging outcomes included mucus score\/volume and air-trapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At week 12, siVaw increased at FRC by 0.16\u2009mL\/L (27%; 95%\u2009CI 0.01% to 0.31%; p\u202f=\u202f0.02) and at TLC by 0.14\u202fmL\/L (14%; 95%\u2009CI 0.03% to 0.25%; p\u202f=\u202f0.02); siRaw at TLC decreased by \u22120.41\u2009kPa\u00b7s\/L (\u221224%; 95%\u2009CI \u22120.80% to \u22120.01%; p\u202f=\u202f0.04). siRaw at FRC increased (2.99\u2009kPa\u00b7s\/L; 95%\u2009CI \u22124.57 to 10.54; p=0.42), with a significant relative change (293%; p=0.03) that lost significance after excluding outliers. siVaw at FRC increased early (week 4: 0.19\u202fmL\/L; 33%; 95%\u2009CI 0.03% to 0.34%; p\u202f=\u202f0.01). At week 12, the mucus score decreased by 0.41 (95% CI \u22120.67 to \u22120.14; p&lt;0.01), and air-trapping by 5.5% (95% CI \u22128.8 to \u22122.1; p\u202f&lt;\u202f0.01). Changes in siVaw and mucus correlated with improvements in forced expiratory volume in 1\u2009s (r\u202f=\u202f0.66\u2009and \u22120.77; both p&lt;0.01) and Saint George\u2019s Respiratory Questionnaire (mucus: r\u202f=\u202f0.45; p\u202f=\u202f0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Benralizumab treatment in SEA was associated with early improvements in airway volume, resistance, mucus and air-trapping, correlating with better lung function and quality of life. These findings support FRI to monitor early treatment effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NL-OMON26915.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003845","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:55:40Z","timestamp":1770796540000},"page":"e003845","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Functional respiratory imaging reveals early structural and functional airway responses to benralizumab in severe eosinophilic asthma"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-1826","authenticated-orcid":false,"given":"Lennart","family":"Conemans","sequence":"first","affiliation":[{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichen","family":"Deng","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4296-5076","authenticated-orcid":false,"given":"Sami O","family":"Simons","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-6356","authenticated-orcid":false,"given":"Frits M E","family":"Franssen","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn A","family":"Spruit","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Research and Development, CIRO, Horn, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Hajian","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, St Jansdal Hospital, Harderwijk, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026021023551109000_13.1.e003845.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"2026021023551109000_13.1.e003845.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.042"},{"key":"2026021023551109000_13.1.e003845.3","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.06.00009801"},{"key":"2026021023551109000_13.1.e003845.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2032506"},{"key":"2026021023551109000_13.1.e003845.5","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"The Lancet"},{"key":"2026021023551109000_13.1.e003845.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703501"},{"key":"2026021023551109000_13.1.e003845.7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2213-2600(20)30414-8","article-title":"Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial","volume":"9","author":"Harrison","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026021023551109000_13.1.e003845.8","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"The Lancet"},{"key":"2026021023551109000_13.1.e003845.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.004"},{"key":"2026021023551109000_13.1.e003845.10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.chest.2022.03.003","article-title":"Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose","volume":"162","author":"McIntosh","year":"2022","journal-title":"Chest"},{"key":"2026021023551109000_13.1.e003845.11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chest.2023.02.009","article-title":"CT Mucus Score and 129Xe MRI Ventilation Defects After 2.5 Years\u2019 Anti-IL-5R\u03b1 in Eosinophilic Asthma","volume":"164","author":"McIntosh","year":"2023","journal-title":"Chest"},{"key":"2026021023551109000_13.1.e003845.12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/17476348.2016.1136216","article-title":"Functional respiratory imaging (FRI) for optimizing therapy development and patient care","volume":"10","author":"Hajian","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"2026021023551109000_13.1.e003845.13","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620916990","article-title":"Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD","volume":"14","author":"De Backer","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"2026021023551109000_13.1.e003845.14","first-page":"263","article-title":"Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS\/LABA\/LAMA","volume":"11","author":"Vos","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026021023551109000_13.1.e003845.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-021-01622-3","article-title":"Functional respiratory imaging in relation to classical outcome measures in cystic fibrosis: a cross-sectional study","volume":"21","author":"Lauwers","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026021023551109000_13.1.e003845.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2026021023551109000_13.1.e003845.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2026021023551109000_13.1.e003845.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150314"},{"key":"2026021023551109000_13.1.e003845.19","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14d29.x"},{"key":"2026021023551109000_13.1.e003845.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(06)80166-6"},{"key":"2026021023551109000_13.1.e003845.21","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201807-485AW"},{"key":"2026021023551109000_13.1.e003845.22","doi-asserted-by":"publisher","DOI":"10.1159\/000347120"},{"key":"2026021023551109000_13.1.e003845.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.041"},{"key":"2026021023551109000_13.1.e003845.24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00362-X"},{"key":"2026021023551109000_13.1.e003845.25","doi-asserted-by":"publisher","DOI":"10.1159\/000530392"},{"key":"2026021023551109000_13.1.e003845.26","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.6.9608027"},{"key":"2026021023551109000_13.1.e003845.27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00114007"},{"key":"2026021023551109000_13.1.e003845.28","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.6.9906075"},{"key":"2026021023551109000_13.1.e003845.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1102LE"},{"key":"2026021023551109000_13.1.e003845.30","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"key":"2026021023551109000_13.1.e003845.31","doi-asserted-by":"publisher","DOI":"10.1177\/009286150804200402"},{"key":"2026021023551109000_13.1.e003845.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107872"},{"key":"2026021023551109000_13.1.e003845.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202308-1413LE"},{"key":"2026021023551109000_13.1.e003845.34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000531196","article-title":"Frequency and Functional Consequences of Low Appendicular Lean Mass and Sarcopenic Obesity in Patients with Asthma Referred for Pulmonary Rehabilitation","volume":"16","author":"Meys","year":"2023","journal-title":"Obes Facts"},{"key":"2026021023551109000_13.1.e003845.35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jaip.2023.02.034","article-title":"Impact of Treatable Traits on Asthma Control and Quality of Life","volume":"11","author":"Janssen","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026021023551109000_13.1.e003845.36","article-title":"Pulmonary rehabilitation versus usual care for adults with asthma","volume":"8","author":"Osadnik","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026021023551109000_13.1.e003845.37","article-title":"Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma","volume":"9","author":"Huang","year":"2024","journal-title":"JCI Insight"},{"key":"2026021023551109000_13.1.e003845.38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2192OC"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:55:43Z","timestamp":1770796543000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,10]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjresp-2025-003845"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003845","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}